Figure 1.

Treatment algorithm for patients diagnosed with epithelial ovarian cancer. CR, complete response; PR, partial response; SD, stable disease; CRS, cytoreductive surgery; Bev, bevacizumab. (A) Current treatment algorithm. (B) Algorithm incorporating results of SOLO-1. (C) Hypothetical algorithm incorporating the potential positive results of PRIMA and PAOLA-1.*Controversial, see text. **At the time of publication Olaparib is the only approved PARPi for this indication. ***preferred method if BRCA positive. Solid lines, preferred treatment option, dashed lines, allowable treatment option.